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Abstract
BACKGROUND: Immune thrombocytopenic purpura (ITP) is an autoimmune disease in which autoantibodies react 
with platelet surface antigens and results in mild to severe thrombocytopenia due to decreased platelet count or 
inhibition of platelet production. Given the relatively high prevalence of ITP among children and the lack of standard 
diagnostic testing for the diagnosis of chronic disease, this study evaluated the predictive value of risk factors for 
chronic ITP in hospitalized patients.
METHODS: This prospective cohort study was performed on 65 children with ITP who referred to Ali Asghar and 
Rasool Akram Hospitals in Tehran, Iran, during the years 2017 and 2018. Relationships between different risk factors, 
including age of diagnosis, gender, white cell count, primary platelet count, mean platelet volume (MPV), history and 
type of the previous patient infection, FCG gene mutation, and type of FCG mutation with a chronic disease incidence 
were investigated using multiple logistic regression model.
RESULTS: Of 65 patients, 31 (47.69%) were male and 34 (52.31%) were female included in the study. Twenty-eight 
patients (43.08%) had acute ITP and 37 (56.92%) had chronic ITP. Frequency of FCG gene mutation in patients 
with chronic and acute type ITP was 16.36% and 7.27%, respectively (p = 0.51). No association was found between 
the history of the previous infection and its type with the chronic incidence of ITP. The multiple logistic regression 
model showed that three factors, including the absolute number of lymphocytes, age of diagnosis, and primary white 
blood cells (WBC) count were directly linked to chronic ITP. Furthermore, three factors of platelet, sex, and MPV 
were indirectly related to chronic ITP. In addition, the absolute number of lymphocytes, age of diagnosis and primary 
WBC count were significantly associated with chronic ITP. The receiver operating characteristic analysis showed that 
the cutoff rate of these factors was 0.31. Further analysis of these risk factors in comparison with the gold standard 
demonstrated that the diagnostic sensitivity and specificity of these risk factors for chronic ITP were 73.08% and their 
specificity was 88.57%, indicating the high importance and predictive power of these risk factors.
CONCLUSIONS: According to the results of this study, for the first time in Iran, six risk factors, including the absolute 
number of lymphocytes, age at diagnosis, sex, MPV level, platelet level at time of diagnosis, and primary WBC 
count were considered as the most important risk factors affecting the incidence of chronic ITP. Of course, more 
comprehensive studies can definitely lead to more comprehensive models.
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Background
Platelets play a very important role in 
homeostasis and their dysfunction (thrombocytopenia) 
results in hemorrhage, especially in the skin and mucosa. 
One of the most common chromosomal abnormalities is 
immune thrombocytopenic purpura (ITP), which has an 
incidence in children of about 2–5 cases/100,000 [1]. ITP 
is considered to be an acquired, auto-immune disorder, 
and up to two criteria are needed for the disease: (a) 
There is only thrombocytopenia and other findings in 
the complete blood count and peripheral blood smear 
is normal, (b) The lack of other clinical conditions 
with similar manifestation such as systemic lupus 
erythematosus (SLE), antiphospholipid syndrome, and 
chronic lymphoid leukemia [2]. The above-mentioned 
patients are considered to be secondary immune 
thrombocytopenia. Infections with infectious agents 
such as human immunodeficiency virus, hepatitis 
c virus, cytomegalovirus, and varicella zoster virus 
can be associated with such antibodies, leading to 
secondary ITP [3]. There are also strong reports about 
the role of Helicobacter pylori infection in the etiology of 
ITP [4]. It is an autoimmune disease that is associated 
with a decrease in platelet count, which may occur with 
a reduction of platelet and platelet life-span. Although 
the earliest mechanism of autoantibody induction is 
no known, these autoantibodies are specific and they 
can be attached to the platelet surface glycoproteins. 
Specific glycoproteins, including GPIIb/IIIa and GPIb/
Ix, can be autoantigen, and due to unknown reason, it 
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can stimulate the immune system, leading to antibody 
production and destruction of platelets [5].
In 75% of cases, autoantibodies are produced 
against one or both of the above glycoproteins, and 
then platelet can be removed from the bloodstream by 
the phagocytosis or complement-mediated lysis [2]. On 
the other hand, antibodies binding to megakaryocytes 
may lead to interruptions in the development of 
megakaryocytes and release of platelets from 
megakaryocytes [5].
The disease can be acute or chronic. In acute 
type, platelet count reaches above 150,000/mm3 after 
6 months and no recurrence occurs. In chronic type, 
low platelet counts persist for more than 6 months [3]. 
Numerous studies have been done in recent decades on 
the prevalence, diagnosis, and treatment of ITP [6], [7], [8], 
but are still open for further investigation and identification 
of predictive factors. In recent years, therapeutic 
indications for reducing intravenous immunoglobulin 
(IVIG) consumption from severe thrombocytopenia 
(<20,000) have led to treatment only under conditions 
of bleeding. However, the implementation of these new 
guidelines, especially in developing countries, has not 
been welcomed by families of children and therapists. 
Therefore, the timing of the disease at the onset of its 
acute form using chronic disease predisposing factors 
may be helpful. Current treatment of ITPs includes the 
use of IVIG or steroids, anti-D, and in some cases only 
the patient is monitored [9]. Old age, female gender, 
and the onset of disease, silence have been suggested 
as risk factors for chronic disease [10], [11], [12], but 
unfortunately it is unclear, which what is the relationship 
between disease time and the number of bone marrow 
megakaryocytes. Given the absence of a standard for 
the chronic type ITP, identifying the risk factors involved 
in the onset and early diagnosis of the disease is very 
valuable. Although several studies have examined the 
risk factors associated with the chronic state of ITP 
disease [10], [11], [12], early diagnosis of the disease 
remains a major concern. Therefore, research on finding 
predictive patterns of various risk factors related to 
chronic disease is very valuable and will greatly help in 
diagnosis, appropriate treatment of disease and reduction 
of the economic burden of society. The aim of this study 
was to evaluate the predictive value of chronic ITP risk 
factors in acute ITP patients referred to Ali Asghar and 
Rasool Akram Hospitals in Tehran, which could lead to a 
predictive model for identifying chronic cases at the time 
of diagnosis and reducing treatment costs.
Materials and Methods
In this prospective cohort study, 65 children under 
the age of 19 who referred to two hospitals of Ali Asghar 
and Rasool Akram for ITP were included in the study.
Sample size
The sample size was calculated based on 
similar studies. In this study, the sample size was 
calculated as 150 patients by considering a confidence 
of 95% (CI = 95%), the significance level of < 0.05, and 
error of 0.08, but only 65 patients were included in the 
study within the prescribed period.
Inclusion criteria
Children under 19 years of age with a diagnosis 
of acute ITP were included in the study.
Exclusion criteria
The following criteria were excluded from the 
study:
1. Patients who did not consent to participate in 
the study
2. Patients who had thrombocytopenia, 
leukopenia, and anemia
3. Patients who had drug-induced 
thrombocytopenia (drugs such as sulfonamides, 
penicillin, anti-tuberculosis drugs, and 
anti-inflammatory drugs such as NSAIDs, 
cimetidine, ranitidine, and anticonvulsants 
such as diazepam, phenytoin, carbamazepine, 
valproic acid, antihypertensive drugs, and heart 
drug such as acetazolamide and captopril)
4. Patients with impaired coagulation tests (PT > 
16s and PT > 42s)
5. Microangiopathic hemolytic anemia patients
6. Patients with underlying diseases such as 
congenital platelet function defects (such as 
syndrome Thrombocytopenia-absent radius 
syndrome, Bernard-Soulier syndrome, and 
von Willebrand syndrome)
7. Patients with leukemia, types of viral hepatitis, 
sepsis, hypersplenism, HIV infection, or 
vascular collagen diseases such as SLE.
Demographic data, including age, sex, and 
history of any familial disease, clinical symptoms, 
manifestations of the disease, and medications taken 
by patients, were included in the data collection 
form. Routine laboratory results of hematology, 
blood smear, and biochemical tests such as CBC, 
white blood cells (WBC), PMN, ESR, mean platelet 
volume (MPV), and CRP were evaluated. History 
of infection and type of infection, including H. pylori 
infection, were also reviewed. Part of the patients’ 
blood samples was also screened for mutations in the 
FCGR2B gene as well as the type of mutation using 
the molecular method. Finally, patients returned to 
the hospital after 6 months and their symptoms, and 
response to treatment were evaluated using a second 
peripheral blood smear test.
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Data analysis
Data were analyzed by SPSS software 
(version 19). Quantitative data were analyzed using the 
descriptive program and presented as Mean ± SD. A 
Chi-square test was used to compare percentages or 
frequencies of qualitative data.
The mean of data was compared between 
the two groups in the chronic and acute groups by 
independent sample t-test. Multiple logistic regression 
tests were used to investigate the relationship between 
different risk factors with chronic disease. In this study, 
p < 0.05 was considered statistically significant.
Results
In this study, 65 patients were included, of 
which 31 (47.69%) were male and 34 (52.31%) were 
female. Of the 65 patients, 28 (43.08%) had acute ITP 
and 37 (56.92%) had chronic ITP. Frequency of male 
and female in acute ITP was equal to 21.54% and in 
chronic ITP was 26.15% and 30.77%, respectively. 
The findings revealed no significant difference in the 
frequency of acute and chronic ITP in terms of gender 
(p = 0.47). Overall, 69.8% had a history of infection 
and 30.2% had no history of infection. The prevalence 
of infection in patients with acute and chronic ITP 
was 35.85% and 33.96%, respectively. There was no 
significant difference between the two groups (p = 0.92).
The results of risk factors between patients with 
chronic and acute ITP showed a significant difference in 
mean primary MPV (p = 0.009), mean age at diagnosis 
(p = 0.003), and lymphocyte count (p = 0.003) between 
the two groups, while no significant difference was 
found in mean platelet-level risk factors at diagnosis 
(p = 0.092) and primary WBC count (p = 0.722).
The mean primary MPV in chronic type ITP 
patients was significantly higher than that in acute 
type of ITP (p = 0.009). Mean age at diagnosis was 
significantly higher in chronic ITP than in acute ITP 
(p = 0.003). The mean lymphocyte count in chronic type 
of ITP was significantly lower than that in acute type of 
ITP patients (p = 0.003) (Table 1).
Table 1: Comparison of the risk factors for chronic ITP among 
all enrolled patients
Risk factors ITP type 2 N Mean SD SEM p-value
Initial MPV Acute 26 10.031 0.6085 0.1193 0.009
Chronic 31 10.610 0.9823 0.1764
Age at diagnosis Acute 28 27.38 33.483 6.328 0.003
Chronic 37 57.81 46.304 7.612
Plt at diagnosis Acute 28 16571.43 17733.477 3351.312 0.092
Chronic 35 25828.57 25130.817 4247.883
Initial WBC Acute 28 8235.71 2071.002 391.383 0.722
Chronic 35 8448.57 2543.547 429.938
Absolute lymph 
count
Acute 26 5700.54 1725.587 338.415 0.003
Chronic 35 4150.03 2140.613 361.830
Chronic 36 22277.77 23044.814 3840.80
WBC: White blood cells, ITP: Immune thrombocytopenic purpura, SEM: Standard error of the mean, 
SD: Standard deviation.
Multiple logistic regression model showed 
that six factors, including lymphocyte count, age at 
diagnosis, primary WBC count, platelet level, sex, and 
MPV, were associated with chronic ITP (Table 2).
Table 2: Multiple logistic regression study of important risk 
factors for chronicity of ITP
Risk factors B SE Wald df Sig. Exp (B)
Step 1a Absolute lymph count 2.261 0.943 5.747 1 0.017 9.591
Age at diagnosis −3.699 1.403 6.948 1 0.008 0.025
Initial Plt group −0.713 0.823 0.751 1 0.386 0.490
Initial WBC 0.000 0.000 4.608 1 0.032 1.000
Sex 0.770 0.809 0.904 1 0.342 2.159
Initial MPV 0.712 0.570 1.559 1 0.212 2.038
Constant −11.449 5.824 3.865 1 0.049 0.000
WBC: White blood cells, ITP: Immune thrombocytopenic purpura, SE: Standard error, MPV: Mean platelet 
volume.
There was no significant difference in the 
frequency of primary platelets <20,000 and ≥20,000 
in patients with acute and chronic ITP (p = 0.24). The 
results showed that there was no significant difference 
in the frequency of patients with acute and chronic 
type ITP based on FCG gene mutation (p = 0.51). 
Approximately 27.27% of patients with acute ITP and 
49.09% of patients with chronic ITP had no mutation in 
this gene. Frequency of FCG gene mutation in patients 
with chronic and acute type ITP was 16.36% and 
7.27%, respectively. There was no significant difference 
in the type of FCG mutation between the two groups 
(p = 0.78) (Figure 1). Frequency of patients based on 
cutoff age at diagnosis (<6 months and equal to or >6 
months) showed a significant difference (p = 0.003). 
Approximately, 52.31% of patients with chronic ITP 
were more than or equal to 6 months of age, while this 
frequency was 26.15% for patients with acute ITP. The 
frequency of patients with chronic and acute ITP in the 
age range below 6 months was 4.62% and 16.92%, 
respectively.
Figure 1: Comparison of frequency of FCG gene mutation among 
patients with acute and chronic immune thrombocytopenic purpura
The frequency of patients based on the cutoff 
number of lymphocytes (<4000 and equal or more 
than 4000) showed significant difference (p = 0.001). 
Approximately 34.43% of patients with chronic ITP had 
a lymphocyte count of <4000, while this frequency was 
only 8.20% for patients with acute ITP. The incidence of 
patients with chronic and acute ITP with a lymphocyte 
count of ≥4000 was 22.95% and 34.43%, respectively.
A comparison of the frequency of patients 
with chronic and acute ITP based on the primary WBC 
cutoff (<7000 and more or equal to 7000) showed no 
significant difference in the frequency of chronic and 
acute ITP based on the primary cutoff WBC (p > 0.05). 
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The frequency of chronic and acute ITP patients with 
<7000 WBC was 12.7% and 20.63%, respectively, 
while the distribution of chronic and acute ITP with 
WBC ≥7000 was determined to be 31.75% and 34.92%, 
respectively 
The minimum cutoff for the diagnosis of 
chronic cases at the time of diagnosis was 0.31 based 
on six factors in the model, including initial absolute 
lymphocyte count, patient age at the time of diagnosis 
of acute disease, initial WBC count, initial MPV, sex, 
and initial platelet count using the receiver operating 
characteristic (ROC) curve (Figure 2).
Figure 2: Calculation of cutoff rate for risk factors
Further analysis of the association of these risk 
factors in comparison with the gold standard showed 
that the diagnostic sensitivity of these risk factors for 
chronic ITP was 73.08%, and their specificity was 
88.57%, indicating the importance and high predictive 
power of these risk factors (Figure 3).
Figure 3: Comparison of sensitivity and specificity of risk factors for 
chronic immune thrombocytopenic purpura
Discussion
The aim of this study was to investigate the 
predictive value of risk factors for chronic ITP in patients 
with acute disease. For the first time, we have come up 
with a model that is able to detect about 90% of early-
stage ITP chronic conditions. The relationship between 
various factors such as age of diagnosis, sex, history, 
and type of infection, mutation and its type in FCG gene, 
platelet count, WBC count, MPV level, and lymphocyte 
count with chronic ITP was evaluated in patients with 
acute disease.
Multiple logistic regressions showed that 
three factors, including absolute lymphocyte count, 
age at diagnosis and WBC count were independently 
associated with the chronic condition of ITP. The ROC 
diagram showed that if the cutoff result of this risk 
factor was >0.31, these risk factors could be used to 
diagnose or predict chronic status of the disease. 
Further analysis of the association of these risk factors 
in comparison with the gold standard demonstrated that 
their diagnostic sensitivity and specificity for chronic 
ITP were 73.08% and 88.57%, respectively, indicating 
the importance and high predictive power of these risk 
factors. This model can identify nearly 90% of those who 
will become chronic. Thus, for the first time, a proposed 
model can detect the chronic state of the disease by 
measuring and evaluating these factors based on the 
cutoff.
In this study, no significant relationship was 
found between FCG gene mutation and its type with 
chronic disease. Furthermore, no relationship was found 
between the history of infection and the type of infection 
with the onset of chronic disease, while some previous 
studies have emphasized on the association of FCG 
mutation and infection, especially H. pylori infection 
with chronic disease. In a study by Bruin et al., the 
association of FCG gene mutation and infection history 
with chronic ITP in 60 pediatric patients showed that the 
I/T genotype of the FCG gene and history of previous 
infection was also significantly associated with the 
development of chronic ITP in children [13]. In another 
study, Foster et al. [14] examined the association of 
FCG gene mutations with chronic ITP in 37 children, 
which the results showed a significant relationship of 
FCG gene mutations (FCGR3A and FCGR3B) with 
incidence of chronic condition.
In a recent study, Pavkovic et al. examined 
the association of FCG gene mutation (FCGR2A) 
with chronic ITP expression in 120 adult ITP patients, 
where a significant association between polymorphism 
in this gene and chronic ITP was observed. However, 
these researchers recommended conducting a study 
with a larger sample size [15]. On the other hand, our 
study there did not demonstrate a relationship of the 
type of FCG genotype and the history of infection with 
chronic disease. Given that the FCG mutation study 
was performed for the first time in a diagnostic center 
in Iran, there is a possibility of error in the results of 
the mutation and may be one of the reasons for the 
lack of significant association between FCG mutation 
and chronic disease in Iran. On the other hand, a 
small sample size of chronic patients may be another 
possible reason for this lack of association. To this end, 
a larger sample size study is needed to investigate the 
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association between FCG mutation or polymorphism 
and the occurrence of chronic ITP.
In a study by El Alfy et al., the diagnostic value 
of various predictive factors for the diagnosis of chronic 
ITP was investigated; their results indicated that 65% of 
patients had acute ITP and 34.9% had chronic ITP [11]. 
Their results also showed that patients with chronic 
disease had a significantly higher mean age at the time 
of diagnosis compared with the acute state, which is 
consistent with our findings.
In our study, the mean age of diagnosis was 
significantly higher in chronic patients than in patients 
with acute disease. They also showed that girls over the 
age of 10 years were significantly more susceptible to 
chronicity than boys. On the other hand, the number of 
primary platelets more than 109 × 20 /L was considered 
as a risk factor for chronic disease. In our study, gender 
and the number of primary platelets were considered as 
one of the major risk factors for chronic disease, which 
is in line with these results. Therefore, according to 
research by these researchers, gender, age above 10 
years, and the primary platelet count was considered 
as important risk factors for chronic ITP [11].
In another study, Ahmed et al. reported the 
association of the absolute number of leukocytes and 
blood lymphocytes in our disease prediction [16], which 
is consistent with the findings of our study. In 2014, 
Dr. Bahosh et al. also confirmed the association of the 
absolute number of blood lymphocytes at the time of 
diagnosis of acute type of disease with its time [17].
In a meta-analysis study by Heitink-Pollé et al., 
54 articles on the diagnostic factors of chronic ITP 
were reviewed and analyzed [10]. Their results showed 
that various factors such as female gender, older age 
(≥11 years), no history of infection or vaccination, 
increased platelet count (>20,000 units/μl), presence 
of antinuclear antibodies, and history of treatment 
with methylprednisolone and IVIG are significantly 
associated with chronic condition of disease. Children 
with mucosal hemorrhage were also significantly less 
susceptible to chronic ITP at the time of diagnosis or 
treatment with IVIG alone. The results of this study 
were largely consistent with the findings of our study. 
Similarly, sex, age, and platelet counts were considered 
as important risk factors for chronic disease in our study. 
In another study, Makis et al. examined the relationship 
of different risk factors with the development of chronic 
ITP in 57 children [12]. Multiple logistic regression 
models were used to investigate the association of 
age, sex, history of infection, type of bleeding, duration 
of symptoms, platelet count at diagnosis, treatment 
process, and immunological markers with chronic ITP.
Their results demonstrated that children 
older than 10 years of age, progressive onset of 
disease, platelet count above 10,000 /μl, and abnormal 
immunological markers were highly associated with 
chronic ITP.
There was no association between history of 
infection and spontaneous bleeding with chronic ITP. 
Therefore, the researchers suggested that several factors 
may have contributed to the chronicity of ITP, which 
warrants further investigation. The results of mentioned 
study were largely consistent with the findings of our 
study. Zeller et al. assessed the relationship between 
different risk factors for the diagnosis of chronic disease 
in 506 children with ITP [18]. The results of their study 
using multiple logistic regression model demonstrated 
that age (0–7 years), gender (girls), and platelet counts 
are the most important risk factors associated with chronic 
disease, which are in line with the results of our study.
Jung et al. investigated the association of 
a variety of clinical and laboratory risk factors in the 
development of chronic disease in 64 children with 
ITP [19]. Their results showed that age, the previous 
history of infection and sudden onset of symptoms are 
the most important risk factors associated with chronic 
ITP. Their results also revealed that among patients 
receiving IVIG, children with a platelet count <45,000 μl 
after 1 month of receiving IVIG had a significantly higher 
prevalence of chronic ITP than children with platelets 
greater than or equal to IVIG.
Another study by Xu et al. evaluated the 
relationship between different risk factors and the 
incidence of chronic disease in 114 children with ITP [20]. 
Their results using multiple logistic regression model 
showed that age and number of post-operative platelets 
are significantly associated with chronic disease.
Coccia et al. investigated the relationship 
between different clinical and laboratory risk factors 
and the incidence of chronic disease in children with 
ITP [21]. Their findings revealed that 20% of patients 
had chronic disease. After further investigation using 
multiple logistic regression model, platelet count was 
an important diagnostic factor for chronic ITP, which is 
in line with our results.
In an old study, Robb et al. examined the 
relationship between various risk factors in the diagnosis 
of chronic ITP in 289 pediatric patients [22]. About 18% 
of patients had a chronic condition. Multiple logistic 
regressions were used to investigate the relationship 
of age, sex, season of onset, recent history of viral 
disease, duration of symptoms, and manifestations with 
chronic ITP. Their results showed that platelet counts 
and a history of disease symptoms longer than 2 weeks 
were considered as important risk factors for chronic 
ITP. They noted that abnormal platelet count after 28 
days of diagnosis is an important diagnostic criterion for 
chronic disease. This study is in line with the results of 
our study. In the present study, platelet count at the time 
of diagnosis was considered as an important diagnostic 
criterion for chronic disease.
Limitations of the study were the lack of parent 
collaboration, as well as the lack of easy access to the 
children with ITP during the study period.
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Conclusions
Given the high diagnostic value and power 
(approximately 90%) and low cost of examining these 
risk factors in comparison to genetic testing, this is a 
very economically valuable issue. On the other hand, 
identifying or diagnosing chronic patients using these 
risk factors does not require costly IVIG treatment 
protocols, and other low-cost therapies may replace 
IVIG for these patients. According to the results of this 
study, for the first time in Iran, six risk factors, including 
absolute number of lymphocytes, age at diagnosis, 
sex, MPV level, platelet level at time of diagnosis, 
and primary WBC count were considered as the most 
important risk factors affecting the incidence of chronic 
ITP.
According to the results of this study, it is 
recommended to perform this suggested pattern for 
the identification of chronic ITP before IVIG therapy. 
However, to introduce this pattern in different treatment 
centers, it is worthwhile to conduct a study with a 
larger sample size at several treatment centers for 
confirmation. It is a worthwhile effort to do further 
research with a larger sample size for investigating the 
association of FCG polymorphism with the occurrence 
of chronic ITP.
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